Views & Analysis Cost concerns with the new NHS pricing scheme A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly.
News FDA issues novel nods for diabetes monitor, migraine lenses In a busy week, the FDA granted two De Novo authorisations for consumer health devices and is rumoured to be mulling structural leadership changes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
